Sun and Novartis settle on Gleevec

15-05-2014

Sun and Novartis settle on Gleevec

Photo: lucarista / Shutterstock.com

Novartis and Sun Pharma’s US subsidiary have settled litigation related to cancer drug Gleevec (imatinib mesylate) in the US, the companies announced today (May 15).


Sun Pharma, Novartis, Gleevec, settlement

LSIPR